‍

Xiamen SpacegenCo., Ltd., integrating R & D, production, sales and advisory services, is dedicated to providing the most innovative products and services for cancer, genetic diseases and other personalized precision medical testing.We provide the products with total solution for early screening, disease diagnosis, personalized drug selection and efficacy monitoring of treatment. 

The company has a strong scientific research and technical team, equipped with high-throughput sequencing platform, digital PCR platform, fluorescence quantitative PCR platform, nucleic acid mass spectrometry platform, etc., and based on this independent research and development of more than 40 kinds of products, applied for 41 domestic patents, 3 international PCT patents, 7 invention patents, 2 utility model patents and 12 soft works have been authorized.

Spacegen has received TUV ISO 13485 certification for medical device quality management. Twenty Two products have been achieved CE certification including Human Oncology Multi-Gene Mutations Detection Kit, Human BRCA1/2 Gene MutationsDetection Kit, Human EGFR Gene Mutations DetectionKit, Human K-ras Gene Mutations Detection Kit ,Human B-raf Gene Mutation Detection Kit,Human Pharmacogenomics SNP Detection Kit,Cardiotoxicity Prediction Of Breast Cancer Detection Kit,Human Radiotherapeutic Side Effect-Related Gene SNP Detection Kit,Human MGMT Gene Methylation Detection Kit and Human EGFR Gene T790M Mutation Detection Kit,etc.CE certifications for  more products are been applied now. 

Spacegen adheres to the business philosophy of ”Quality first, credibility focused, management oriented, service centered”, and abides by the corporate culture of "giving each patient accurate diagnosis and effective treatment!".Spacegen commits to becoming a pioneer enterprise in personalized precision medical industry and strives for the cause of human health by providing the majority of medical workers and patients with professional, high-quality precision medical solutions.